Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

SCALE™ Insulin

Novo Nordisk · Phase 3 · Completed · Enrollment 396

NCT02963922

EudraCT 2015-005619-33

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

51.823.98
≥5%
22.776.55
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
liraglutide 3.0 mg51.8%22.77%n/rn/r
Placebo23.98%6.55%n/rn/r

Not shown

Every selected arm is drawn.